Peds RAP - Nirsevimab: The Latest Tool to Prevent RSV
Podcast: Hippo Education Presents: The Monthly RoundsPublished On: Thu Dec 19 2024
Description: Nirsevimab - the new RSV monoclonal antibody has been FDA approved for use in infants. Parul and Sol review what it is, how effective it is in preventing severe RSV bronchiolitis, and who should receive it. Explore Our Podcasts: hippoed.com/podcasts
The note was deleted
The note was saved
Your message was sent